Clinical Trial Update: Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid [Phase 2]

View source ↗

Summary

A Phase 2 safety, tolerability, and immunogenicity study of an investigational recombinant botulinum vaccine A/B in volunteers previously immunized with an inve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Botulism

Drugs mentioned

• Investigational Pentavalent Botulinum Toxoid (pentavalent botulinum toxoid)
• Investigational Recombinant Botulinum Vaccine A/B (recombinant botulinum vaccine A/B)

Snippet

Sponsor: California Department of Public Health | Conditions: Botulism | Phase 2 | Status: COMPLETED | Results posted: 2017-02-09